BHC (Bausch Health) Institutional Ownership: 65.21% (As of Jul. 05, 2026)


BHC Bausch Health Companies Inc BHC
58 GF Score
Price $4.90
GF Value $7.85
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Institutional Ownership?

Bausch Health BHC +2.73% 58 Institutional Ownership is 65.21% as of Jul. 05, 2026. GuruFocus rates BHC with a GF Score™ of 58/100 and a GF Value™ of $7.85 (Possible Value Trap). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bausch Health's institutional ownership is 65.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bausch Health's Insider Ownership is 4.31%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bausch Health's Float Percentage Of Total Shares Outstanding is 79.96%.

Bausch Health Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Bausch Health's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Institutional Ownership Chart

Bausch Health Historical Data

The historical data trend for Bausch Health can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 11.15 11.04 11.17 12.23 13.05 14.00 10.16 10.78 11.11 11.26
BHC
58GF Score
Bausch Health Companies Inc BHC
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 65.21% mean?
Bausch Health (BHC) has a Institutional Ownership of 65.21% as of Jul. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bausch Health and its competitors.
Is Bausch Health's Institutional Ownership too high?
Bausch Health's current Institutional Ownership is 65.21%. Overall, Bausch Health has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Institutional Ownership compare to ZTS and UTHR?
Bausch Health's Institutional Ownership of 65.21% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bausch Health and its competitors. Bausch Health's current Institutional Ownership is 65.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (BHC) is currently considered Possible Value Trap. The stock's GF Value™ is $7.85, compared to a current price of $4.90 — trading 37.6% below its estimated fair value. The current Institutional Ownership is 65.21%. Bausch Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Bausch Health (BHC), the current Institutional Ownership is 65.21% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of $4.90 is trading 37.6% below its estimated GF Value™ of $7.85. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for BHC:

  • Institutional Ownership: 65.21%
  • GF Value™: $7.85 vs. price of $4.90 (37.6% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
58GF Score

Get the complete analysis for BHC

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.90
Price
$7.85
GF Value